Try our beta test site

Phase I Study of AT13148, a Novel AGC Kinase Inhibitor

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2017 by Cancer Research UK
Sponsor:
Information provided by (Responsible Party):
Cancer Research UK
ClinicalTrials.gov Identifier:
NCT01585701
First received: April 25, 2012
Last updated: January 25, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Study Completion Date: No date given
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)